ASSESSMENT OF DRUG INTERACTIONS WITH IPTACOPAN
Back
Abstract Number
WCN23-0372
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Other CKD
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
ASSESSMENT OF DRUG INTERACTIONS WITH IPTACOPAN
Co-authors
Schmouder, R.(1)*;Shah, B.(1);Taylor, A.(1);Nidamarthy, P.K.(2);Kulmatycki, K.(3);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Novartis Pharmaceuticals Corporation, Translational Medicine, East Hanover, United States;(2)Novartis Healthcare Pvt. Ltd., Biostatistics & Pharmacometrics, Hyderabad, India;(3)Novartis Institutes Of Biomedical Research, Translational Medicine, Cambridge, United States;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/095ef1bcd0753461dfcd44e826fe36e8.pdf
Audio File
https://storage.unitedwebnetwork.com/files/1041/0a276011900c95e81614d12583486d22.mp3
if any